• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    7/26/24 9:00:00 AM ET
    $BTCY
    $LOBO
    Medical/Dental Instruments
    Health Care
    Motor Vehicles
    Consumer Discretionary
    Get the next $BTCY alert in real time by email

    ORLANDO, FL / ACCESSWIRE / July 26, 2024 / RedChip Companies will air interviews with LOBO EV Technologies Ltd. (NASDAQ:LOBO) and Biotricity, Inc. (NASDAQ:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 27, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

    Access the interviews in their entirety at:

    • LOBO EV: https://www.redchip.com/assets/access/lobo_access

    • Nexalin: https://www.redchip.com/assets/access/nxl_access

    In an exclusive interview, Harry Schulman, an independent director of LOBO EV, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate update. LOBO EV, headquartered in Wuxi, China, is a pioneering OEM and ODM manufacturer and seller of electric vehicles (EVs), including e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles, tailored for various demographics, including mobility solutions for the elderly and disabled. Beyond vehicle manufacturing, LOBO EV offers automobile information and entertainment software development services to industry OEMs. The Company has a proven track record of leveraging advanced technologies in connectivity, multimedia, interactive systems, and artificial intelligence to enhance user experience with affordable, convenient, and enjoyable driving solutions. The Chinese e-bike market, currently valued at $16 billion, is forecasted to nearly double, reaching $31.3 billion in the next five years with a compound annual growth rate (CAGR) of 11.76%, according to Research and Markets. LOBO EV's robust financial performance across its key segments, coupled with the vast market opportunities within China's EV industry, position LOBO EV for significant upside.

    Mark White, CEO of Nexalin, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate update. Nexalin stands at the forefront of the mental health treatment revolution with its cutting-edge, non-invasive neurostimulation technology. By focusing on deep brain stimulation, Nexalin's devices, particularly the advanced Gen-3 HALO™ Clarity, offer a groundbreaking alternative to traditional pharmacological treatments. This technology has shown clinically meaningful improvements in treating conditions such as insomnia, PTSD, and traumatic brain injuries - conditions that affect millions but have limited effective treatments - positioning Nexalin as an emerging leader in a market poised for substantial growth, projected to reach $537 billion by 2030.

    About LOBO EV Technologies Ltd.

    LOBO is an innovative designer, developer, manufacturer and seller of e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons. LOBO also provides automobile information and entertainment software development and design services to customers. Leveraging its cutting-edge technologies in connectivity, multimedia interactive systems and artificial intelligence, LOBO re-defines and develops its products in order to provide users with convenient, affordable and pleasant driving experiences. For more information, visit: https://loboev.io/.

    About Nexalin

    Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin's products are believed to be non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin believes the deeper-penetrating waveform in its next-generation devices will generate enhanced patient response without any adverse side effects. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil, and Oman. Additional information about the Company is available at: https://nexalin.com/.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 32 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.

    To learn more about RedChip's products and services, please visit:

    https://www.redchip.com/corporate/investor_relations

    "Discovering Tomorrow's Blue Chips Today"™

    Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

    Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

    Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

    Follow RedChip on Twitter: https://twitter.com/RedChip

    Follow RedChip on YouTube: https://www.youtube.com/@redchip

    Follow RedChip on Rumble: https://rumble.com/c/c-3068340

    Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

    Contact:

    Dave Gentry
    RedChip Companies Inc.
    1-407-644-4256
    [email protected]

    --END--

    SOURCE: RedChip



    View the original press release on accesswire.com

    Get the next $BTCY alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BTCY
    $LOBO

    CompanyDatePrice TargetRatingAnalyst
    Biotricity Inc.
    $BTCY
    11/20/2023Buy → Neutral
    H.C. Wainwright
    Biotricity Inc.
    $BTCY
    3/7/2022$5.00Buy
    Lake Street
    Biotricity Inc.
    $BTCY
    11/23/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BTCY
    $LOBO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LOBO EV Technologies Ltd. Issues Statement Regarding Recent Market Activity

      WUXI, China, July 25, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (NASDAQ:LOBO) ("LOBO" or the "Company"), a developer and manufacturer in electric mobility and intelligent systems, today issued a statement regarding recent trading activity in its common stock. The Company has observed an increase in trading volume and a corresponding decline in its share price over the past several days. While LOBO does not generally comment on market activity or fluctuations in its stock price, the Company confirms that there have been no material changes to its business operations or strategic direction that would warrant such activity. The Company continues to operate in the ordinary course of

      7/25/25 8:54:37 AM ET
      $LOBO
      Motor Vehicles
      Consumer Discretionary
    • LOBO EV (NASDAQ: LOBO) Unveils $3 Million Annual Revenue Opportunity with AI-Powered Senior Mobility Robot Launching October 2025

      WUXI, China, July 22, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (NASDAQ:LOBO) ("LOBO" or the "Company"), a leading manufacturer and innovator in electric mobility and intelligent systems, today announced a strategic partnership with the Jiangsu Research Institute of Dalian University of Technology. This collaboration represents a major advancement in LOBO's expansion into the smart healthcare sector, as both parties will co-develop and commercialise a next-generation AI-powered senior mobility robot. The robot is expected to launch commercially in October 2025 and is projected to generate approximately USD 3 million in recurring annual revenue. Designed to address the rising glob

      7/22/25 8:30:00 AM ET
      $LOBO
      Motor Vehicles
      Consumer Discretionary
    • Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach

      FY25 revenue up 14.3% YOYFY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continueFY25 operating expenses lower by 24.5% YOYNegative EBITDA reduced by $5.7 million to $3.2 million – an improvement of 63.9%Positive Adjusted EBITDA of $438,260 in the fourth quarter of FY25 – first time in Company's history, highlighting Company's ability to achieve breakeven and EBITDA positive in the early part of its FY26 REDWOOD CITY, CA, July 17, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company that offers innovative diagnostic, chroni

      7/17/25 9:33:00 AM ET
      $BTCY
      Medical/Dental Instruments
      Health Care

    $BTCY
    $LOBO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Rosa David A

      4 - BIOTRICITY INC. (0001630113) (Issuer)

      3/15/23 4:22:52 PM ET
      $BTCY
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Al-Siddiq Waqaas

      4 - BIOTRICITY INC. (0001630113) (Issuer)

      3/14/23 4:26:54 PM ET
      $BTCY
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Ayanoglou John

      4 - BIOTRICITY INC. (0001630113) (Issuer)

      3/13/23 4:10:59 PM ET
      $BTCY
      Medical/Dental Instruments
      Health Care

    $BTCY
    $LOBO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Biotricity downgraded by H.C. Wainwright

      H.C. Wainwright downgraded Biotricity from Buy to Neutral

      11/20/23 7:21:43 AM ET
      $BTCY
      Medical/Dental Instruments
      Health Care
    • Lake Street initiated coverage on Biotricity with a new price target

      Lake Street initiated coverage of Biotricity with a rating of Buy and set a new price target of $5.00

      3/7/22 9:01:18 AM ET
      $BTCY
      Medical/Dental Instruments
      Health Care
    • HC Wainwright & Co. initiated coverage on Biotricity with a new price target

      HC Wainwright & Co. initiated coverage of Biotricity with a rating of Buy and set a new price target of $6.00

      11/23/21 6:29:32 AM ET
      $BTCY
      Medical/Dental Instruments
      Health Care

    $BTCY
    $LOBO
    SEC Filings

    See more
    • Amendment: SEC Form 6-K/A filed by LOBO EV TECHNOLOGIES LTD.

      6-K/A - LOBO EV TECHNOLOGIES LTD (0001932072) (Filer)

      7/17/25 9:00:31 AM ET
      $LOBO
      Motor Vehicles
      Consumer Discretionary
    • SEC Form 6-K filed by LOBO EV TECHNOLOGIES LTD.

      6-K - LOBO EV TECHNOLOGIES LTD (0001932072) (Filer)

      7/16/25 4:30:19 PM ET
      $LOBO
      Motor Vehicles
      Consumer Discretionary
    • SEC Form 10-K filed by Biotricity Inc.

      10-K - BIOTRICITY INC. (0001630113) (Filer)

      7/15/25 5:27:01 PM ET
      $BTCY
      Medical/Dental Instruments
      Health Care

    $BTCY
    $LOBO
    Financials

    Live finance-specific insights

    See more
    • Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach

      FY25 revenue up 14.3% YOYFY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continueFY25 operating expenses lower by 24.5% YOYNegative EBITDA reduced by $5.7 million to $3.2 million – an improvement of 63.9%Positive Adjusted EBITDA of $438,260 in the fourth quarter of FY25 – first time in Company's history, highlighting Company's ability to achieve breakeven and EBITDA positive in the early part of its FY26 REDWOOD CITY, CA, July 17, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company that offers innovative diagnostic, chroni

      7/17/25 9:33:00 AM ET
      $BTCY
      Medical/Dental Instruments
      Health Care
    • Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

      Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, will host its Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18, 2025. The Company announces the best financial performance thus far and a shift to positive adjusted EBITDA. Biotricity's Founder and CEO, Dr. Waqaas Al-Siddiq, and CFO, John Ayanoglou, will deliver remarks followed by a Q

      7/15/25 5:05:00 PM ET
      $BTCY
      Medical/Dental Instruments
      Health Care
    • Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed

      REDWOOD CITY, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) a leading Technology-as-a-Service (Taas) company specializing in cutting-edge diagnostic and chronic disease management solutions for healthcare providers and consumers, is proud to announce its inclusion on the Financial Times' list of The Americas' Fastest-Growing Companies 2025. This recognition highlights Biotricity's innovation in digital health and exceptional growth of 256.4% during a period marked by unprecedented global challenges. Now in its sixth year, the Financial Times, in partnership with the research firm Statista, evaluated independent companies across the Americas based on disclosed rev

      4/8/25 8:15:00 AM ET
      $BTCY
      Medical/Dental Instruments
      Health Care

    $BTCY
    $LOBO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Biotricity Inc.

      SC 13G/A - BIOTRICITY INC. (0001630113) (Subject)

      11/14/24 6:06:28 PM ET
      $BTCY
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by LOBO EV TECHNOLOGIES LTD.

      SC 13D - LOBO EV TECHNOLOGIES LTD (0001932072) (Subject)

      10/11/24 4:05:30 PM ET
      $LOBO
      Motor Vehicles
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by LOBO EV TECHNOLOGIES LTD.

      SC 13G/A - LOBO EV TECHNOLOGIES LTD (0001932072) (Subject)

      10/1/24 5:00:21 PM ET
      $LOBO
      Motor Vehicles
      Consumer Discretionary